Chris Heminway, Exec-Chair at Time To ACT, explains why now is the right time for the Group to IPO. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksVersarien Regulatory News (VRS)

Share Price Information for Versarien (VRS)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 0.0982
Bid: 0.098
Ask: 0.1045
Change: -0.0023 (-2.29%)
Spread: 0.0065 (6.633%)
Open: 0.10
High: 0.10
Low: 0.0982
Prev. Close: 0.1005
VRS Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Placing and Update on Turnaround Strategy

3 May 2023 09:30

RNS Number : 2668Y
Versarien PLC
03 May 2023
 

 

 

 

THIS ANNOUNCEMENT CONTAINS INSIDE INFORMATION FOR THE PURPOSES OF THE MARKET ABUSE REGULATION (EU) 596/2014 (AS AMENDED) AS IT FORMS PART OF THE DOMESTIC LAW OF THE UNITED KINGDOM BY VIRTUE OF THE EUROPEAN UNION (WITHDRAWAL) ACT 2018 (AS AMENDED). UPON PUBLICATION OF THIS ANNOUNCMENT, THIS INSIDE INFORMATION IS NOW CONSIDERED TO BE IN THE PUBLIC DOMAIN.

 

3 May 2023

 

Versarien plc

 

("Versarien" or the "Company")

 

Placing to raise £531,624 and Update on Turnaround Strategy

 

Versarien plc (AIM: VRS), the advanced materials engineering group, announces a placing to raise £531,624 (before expenses) and an update on the Company's turnaround strategy.

 

Placing

 

The Company has raised £531,624 (before expenses) by way of a placing (the "Placing") of 42,529,900 new ordinary shares in the capital of the Company ("Placing Shares") at a price of 1.25 pence per share (the "Placing Price").

 

The net proceeds of the Placing will be used for general operational and working capital purposes and for commercialisation activities primarily in the construction and leisure sectors, in line with the Company's new strategic roadmap which is being finalised.

 

The issue of the Placing Shares uses the authorities granted by shareholders at the Annual General Meeting of the Company ("AGM") held on 29 March 2023 and therefore no shareholder approval is required for the Placing.

 

Turnaround strategy

 

As announced on 29 March at the time of the AGM, David Stone and his team at Prompt Business Strategies Limited have been engaged to aid the Board in developing both its strategic and management plans. Since the AGM, David and his team have been working closely with the Board to develop a strategy that seeks to preserve appropriate intellectual property within the Company, whilst significantly reducing operational costs to facilitate a cash runway that will allow Versarien to deliver commercially in its targeted markets. The new strategic roadmap and financial plan will be announced in the coming weeks.

 

In addition, the Company continues to progress and assess asset disposal options, including disposing of the mature businesses, that are no longer core activities for Versarien.

 

Further updates will be announced in due course as appropriate.

 

Chris Leigh, Chief Financial Officer of Versarien, commented: "As previously announced, the Company requires further funding to support its activities and the Board welcomes the investor interest in this Placing. We continue to focus on completing our strategic reorganisation and commercial roadmap and look forward to sharing this with shareholders in due course."

 

Admission and Total Voting Rights

 

Application will be made for admission of the Placing Shares to be admitted to trading on AIM ("Admission") on or around 10 May 2023. The Placing Shares will rank pari passu in all respects with the Company's existing ordinary shares. Following Admission, the total number of ordinary shares in the Company in issue will be 265,779,690. This figure may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in the Company under the FCA's Disclosure and Transparency Rules.

 

For further information please contact:

 

Versarien

Chris Leigh, Chief Financial Officer

Stephen Hodge, Chief Technology Officer

c/o IFC

SP Angel Corporate Finance (Nominated Adviser and Broker)

Matthew Johnson, Adam Cowl

+44(0) 203 470 0470

 

 

IFC Advisory Limited (Financial PR and Investor Relations)

Tim Metcalfe, Zach Cohen

+44 (0) 20 3934 6630

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
IOEFIFFTESIVIIV
Date   Source Headline
7th Jun 20182:00 pmRNSPrice Monitoring Extension
7th Jun 20187:00 amRNSVersarien appointed to NGA Industry Council
29th May 20187:00 amRNSConsumer Goods Collaboration
22nd May 20187:00 amRNSAppointment of senior DIT secondee
4th May 20187:00 amRNSChange of Nominated Adviser and Broker
30th Apr 20187:00 amRNSAgreement with Luxus
16th Apr 20187:25 amRNSGraphene Supply to Major Tyre Producer
3rd Apr 20181:32 pmRNSHolding(s) in Company
28th Mar 20187:00 amRNSHexotene Product Launch
27th Mar 20187:00 amRNSCollaboration with World Leading Aerospace Group
14th Mar 20187:00 amRNSCollaboration with Team Sky
7th Mar 20181:15 pmRNSAdditional Investor Event
7th Mar 20187:00 amRNSInvestor Event
27th Feb 20184:41 pmRNSSecond Price Monitoring Extn
27th Feb 20184:35 pmRNSPrice Monitoring Extension
27th Feb 20187:00 amRNSAgreement with Vivobarefoot
21st Feb 20187:00 amRNSMedical Technology Collaboration
5th Feb 20187:00 amRNSAppointment to US National Graphene Advisory Board
2nd Feb 20184:40 pmRNSHolding(s) in Company
29th Jan 20183:18 pmRNSExercise of Options
23rd Jan 20183:33 pmRNSHolding(s) in Company
15th Jan 20182:05 pmRNSSecond Price Monitoring Extn
15th Jan 20182:00 pmRNSPrice Monitoring Extension
15th Jan 201811:05 amRNSSecond Price Monitoring Extn
15th Jan 201811:00 amRNSPrice Monitoring Extension
15th Jan 20189:05 amRNSSecond Price Monitoring Extn
15th Jan 20189:00 amRNSPrice Monitoring Extension
15th Jan 20187:00 amRNSPlanned Chinese graphene manufacturing facility
8th Jan 20187:00 amRNSAgreement with Global Apparel Manufacturer
5th Jan 201811:05 amRNSDirector/PDMR Shareholding
4th Jan 20182:05 pmRNSSecond Price Monitoring Extn
4th Jan 20182:00 pmRNSPrice Monitoring Extension
7th Dec 20177:00 amRNSExercise of Options
4th Dec 201711:05 amRNSSecond Price Monitoring Extn
4th Dec 201711:00 amRNSPrice Monitoring Extension
4th Dec 20179:00 amRNSPrice Monitoring Extension
4th Dec 20177:00 amRNSAgreement with Global Chemical Major
1st Dec 20172:05 pmRNSSecond Price Monitoring Extn
1st Dec 20172:00 pmRNSPrice Monitoring Extension
29th Nov 20177:00 amRNSInterim Results
28th Nov 20172:05 pmRNSSecond Price Monitoring Extn
28th Nov 20172:00 pmRNSPrice Monitoring Extension
21st Nov 20179:05 amRNSSecond Price Monitoring Extn
21st Nov 20179:00 amRNSPrice Monitoring Extension
17th Nov 20177:00 amRNSCollaboration with Global Consumer Goods Company
7th Nov 20174:40 pmRNSSecond Price Monitoring Extn
7th Nov 20174:35 pmRNSPrice Monitoring Extension
7th Nov 20173:07 pmRNSHolding(s) in Company
6th Nov 20177:00 amRNSSuccessful Fundraising of £2.9 million
3rd Nov 20174:43 pmRNSFundraising of approximately £1.2 million

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.